Clinical Trial Update: Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of fluvastatin on biomarkers in women undergoing surgery for ductal carcinoma in situ or stage I breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• Fluvastatin (fluvastatin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED